Biomedical Engineering Reference
In-Depth Information
References
Andre N, Carre M, Brasseur G, Pourroy B, Kovacic H, Briand C, Braguer D (2002) Paclitaxel
targets mitochondria upstream of caspase activation in intact human neuroblastoma cells.
FEBS Lett 532 (1-2):256-260
Arnheiter H, Haller O (1988) Antiviral state against influenza virus neutralized by microinjection
of antibodies to interferon-induced Mx proteins. Embo J 7 (5):1315-1320
Astriab-Fisher A, Sergueev D, Fisher M, Shaw BR, Juliano RL (2002) Conjugates of antisense
oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular
uptake, binding to target sequences, and biologic actions. Pharm Res 19 (6):744-754
Bareford LM, Swaan PW (2007) Endocytic mechanisms for targeted drug delivery. Adv Drug
Deliv Rev 59 (8):748-758
Biswas S, Sawant RR, Koshkaryev A, Torchilin VP Novel Rhodamine 123-Conjugated
Pharmaceutical Nanocarrier Targets Mitochondria. In: 37th Annual Meeting and Exposition of
the Controlled Release Society, Portland, OR, USA, 2010
Boddapati SV, D'Souza GG, Erdogan S, Torchilin VP, Weissig V (2008) Organelle-targeted nano-
carriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity
in vitro and in vivo. Nano Lett 8 (8):2559-2563
Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, Ojcius DM, Jaattela M,
Kroemer G (2003) Lysosomal membrane permeabilization induces cell death in a mitochon-
drion-dependent fashion. J Exp Med 197 (10):1323-1334
Chakrabarti R, Wylie DE, Schuster SM (1989) Transfer of monoclonal antibodies into mammalian
cells by electroporation. J Biol Chem 264 (26):15494-15500
Chen LB, Summerhayes IC, Johnson LV, Walsh ML, Bernal SD, Lampidis TJ (1982) Probing
mitochondria in living cells with rhodamine 123. Cold Spring Harb Symp Quant Biol 46 Pt
1:141-155
Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422 (6927):37-44
Cryan SA, Devocelle M, Moran PJ, Hickey AJ, Kelly JG (2006) Increased intracellular targeting
to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for
inhalation. Mol Pharm 3 (2):104-112
D'Souza GG, Weissig V (2009) Subcellular targeting: a new frontier for drug-loaded pharmaceuti-
cal nanocarriers and the concept of the magic bullet. Expert Opin Drug Deliv 6
(11):1135-1148
de la Fuente JM, Berry CC (2005) Tat peptide as an efficient molecule to translocate gold nano-
particles into the cell nucleus. Bioconjug Chem 16 (5):1176-1180
Dodd CH, Hsu HC, Chu WJ, Yang P, Zhang HG, Mountz JD, Jr., Zinn K, Forder J, Josephson L,
Weissleder R, Mountz JM, Mountz JD (2001) Normal T-cell response and in vivo magnetic
resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamag-
netic nanoparticles. J Immunol Methods 256 (1-2):89-105
Fan W (1999) Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol 57
(11):1215-1221
Frankel AD, Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency
virus. Cell 55 (6):1189-1193
Fretz MM, Koning GA, Mastrobattista E, Jiskoot W, Storm G (2004) OVCAR-3 cells internalize
TAT-peptide modified liposomes by endocytosis. Biochim Biophys Acta 1665 (1-2):48-56
Futerman AH, van Meer G (2004) The cell biology of lysosomal storage disorders. Nat Rev Mol
Cell Biol 5 (7):554-565.
Gabizon A, Shmeeda H, Horowitz AT, Zalipsky S (2004) Tumor cell targeting of liposome-
entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev
56 (8):1177-1192
Grabowski GA (2008) Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet 372
(9645):1263-1271
Grabowski GA, Hopkin RJ (2003) Enzyme therapy for lysosomal storage disease: principles,
practice, and prospects. Annu Rev Genomics Hum Genet 4:403-436
Search WWH ::
Custom Search